Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.13.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.28NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAZNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.4.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.3.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BL.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.47NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ED.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CQ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.38.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.19.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.43NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.214NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.284NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.351.3 (Beta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.318NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
R.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19749.2South Korea
AY.29 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
ML.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.283NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.96NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
L.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.310NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.185NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.329NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.229NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.342NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.90NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.169NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used